Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' TEICHER BA' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 128 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Shih, C; Teicher, BA
      Cryptophycins: A novel class of potent antimitotic antitumor depsipeptides

      CURRENT PHARMACEUTICAL DESIGN
    2. Teicher, BA; Menon, K; Alvarez, E; Galbreath, E; Shih, C; Faul, M
      Antiangiogenic and anitumor effects of a protein kinase C beta inhibitor in human T98G glioblastoma multiforme xenografts

      CLINICAL CANCER RESEARCH
    3. Herbst, RS; Lynch, C; Vasconcelles, M; Teicher, BA; Strauss, G; Elias, A; Anderson, I; Zacarola, P; Dang, NH; Leong, T; Salgia, R; Skarin, AT
      Gemcitabine and vinorelbine in patients with advanced lung cancer: preclinical studies and report of a phase I trial

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    4. Lu, K; Dempsey, J; Schultz, RM; Shih, C; Teicher, BA
      Cryptophycin-induced hyperphosphorylation of Bcl-2, cell cycle arrest and growth inhibition in human H460NSCLC cells

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    5. Asea, A; Mallick, R; Lechpammer, S; Ara, G; Teicher, BA; Fiorentino, S; Stevenson, MA; Calderwood, SK
      Cyclooxygenase inhibitors are potent sensitizers of prostate tumours to hyperthermia and radiation

      INTERNATIONAL JOURNAL OF HYPERTHERMIA
    6. Asea, A; Ara, G; Teicher, BA; Stevenson, MA; Calderwood, SK
      Effects of the flavonoid drug Quercetin on the response of human prostate tumours to hyperthermia in vitro and in vivo

      INTERNATIONAL JOURNAL OF HYPERTHERMIA
    7. Teicher, BA
      Molecular targets and cancer therapeutics: discovery, development and clinical validation

      DRUG RESISTANCE UPDATES
    8. Teicher, BA; Chen, V; Shih, C; Menon, K; Forler, PA; Phares, VG; Amsrud, T
      Treatment regimens including the multitargeted antifolate LY231514 in human tumor xenografts

      CLINICAL CANCER RESEARCH
    9. Liu, PC; Menon, K; Alvarez, E; Lu, K; Teicher, BA
      Transforming growth factor-beta and response to anticancer therapies in human liver and gastric tumors in vitro and in vivo

      INTERNATIONAL JOURNAL OF ONCOLOGY
    10. Lu, K; Shih, C; Teicher, BA
      Expression of pRB, cyclin/cyclin-dependent kinases and E2F1/DP-1 in human tumor lines in cell culture and in xenograft tissues and response to cell cycle agents

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    11. Menon, K; Alvarez, E; Forler, P; Phares, V; Amsrud, T; Shih, C; Al-Awar, R; Teicher, BA
      Antitumor activity of cryptophycins: effect of infusion time and combination studies

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    12. Teicher, BA; Frei, E
      Laboratory models to evaluate new agents for the systemic treatment of lung cancer

      MULTIMODALITY TREATMENT OF LUNG CANCER
    13. Teicher, BA; Ara, G; Herbst, R; Palombella, VJ; Adams, J
      The proteasome inhibitor PS-341 in cancer therapy

      CLINICAL CANCER RESEARCH
    14. Teicher, BA; Alvarez, E; Liu, PC; Lu, K; Menon, K; Dempsey, J; Schultz, RM
      MTA (LY231514) in combination treatment regimens using human tumor xenografts and the EMT-6 murine mammary carcinoma

      SEMINARS IN ONCOLOGY
    15. Halpern, HJ; Chandramouli, GVR; Barth, ED; Yu, C; Peric, M; Grdina, DJ; Teicher, BA
      Diminished aqueous microviscosity of tumors in murine models measured within vivo radiofrequency electron paramagnetic resonance

      CANCER RESEARCH
    16. Cenni, B; Kim, HK; Bubley, GJ; Aebi, S; Fink, D; Teicher, BA; Howell, S; Christen, RD
      Loss of DNA mismatch repair facilitates reactivation of a reporter plasmiddamaged by cisplatin

      BRITISH JOURNAL OF CANCER
    17. Teicher, BA
      Sarcomas

      HUMAN CELL CULTURE, VOL. I
    18. Teicher, BA
      Potentiation of cytotoxic cancer therapies by antiangiogenic agents

      ANTIANGIOGENIC AGENTS IN CANCER THERAPY
    19. TEICHER BA
      ROLE OF ANGIOGENESIS IN THE RESPONSE TO ANTICANCER THERAPIES

      DRUG RESISTANCE UPDATES
    20. ELIAS AD; WHEELER C; AYASH LJ; SCHWARTZ G; IBRAHIM J; MILLS L; MCCAULEY M; COLEMAN N; WARREN D; SCHNIPPER L; ANTMAN KH; TEICHER BA; FREI E
      DOSE-ESCALATION OF THE HYPOXIC CELL SENSITIZER ETANIDAZOLE COMBINED WITH IFOSFAMIDE, CARBOPLATIN, ETOPOSIDE, AND AUTOLOGOUS HEMATOPOIETIC STEM-CELL SUPPORT

      Clinical cancer research
    21. TEICHER BA; ARA G; KEYES SR; HERBST RS; FREI E
      ACUTE IN-VIVO RESISTANCE IN HIGH-DOSE THERAPY

      Clinical cancer research
    22. TEICHER BA; ARA G; KEYES SR; HERBST RS; FREI E
      ACUTE IN-VIVO RESISTANCE IN HIGH-DOSE THERAPY

      Clinical cancer research
    23. TEICHER BA; ARA G; CHEN YN; RECHT A; COLEMAN CN
      INTERACTION OF TOMUDEX WITH RADIATION IN-VITRO AND IN-VIVO

      International journal of oncology
    24. HERBST RS; TEICHER BA
      PACLITAXEL CARBOPLATIN ADMINISTRATION ALONG WITH ANTI-ANGIOGENIC THERAPY IN NONSMALL CELL LUNG AND BREAST-CARCINOMA MODELS/

      Annals of oncology
    25. TEICHER BA; ALVAREZ E; LU K; MENON K; DEMPSEY J; SCHULTZ R
      MTA (LY231514) IN COMBINATION TREATMENT REGIMENS USING HUMAN TUMOR XENOGRAFTS AND EMT-6 MURINE MAMMARY-CARCINOMA

      Annals of oncology
    26. EDER JP; CHAN V; WONG J; WONG YW; ARA G; NORTHEY D; RIZVI N; TEICHER BA
      SEQUENCE EFFECT OF IRINOTECAN (CPT-11) AND TOPOISOMERASE-II INHIBITORS IN-VIVO

      Cancer chemotherapy and pharmacology
    27. TEICHER BA; WONG JS; TAKEUCHI H; GRAVELIN LM; ARA G; BUXTON D
      ALLOSTERIC EFFECTORS OF HEMOGLOBIN AS MODULATORS OF CHEMOTHERAPY AND RADIATION-THERAPY IN-VITRO AND IN-VIVO

      Cancer chemotherapy and pharmacology
    28. HERBST RS; TAKEUCHI H; TEICHER BA
      PACLITAXEL CARBOPLATIN ADMINISTRATION ALONG WITH ANTIANGIOGENIC THERAPY IN NON-SMALL-CELL LUNG AND BREAST-CARCINOMA MODELS/

      Cancer chemotherapy and pharmacology
    29. TEICHER BA; WILLIAMS JI; TAKEUCHI H; ARA G; HERBST RS; BUXTON D
      POTENTIAL OF THE AMINOSTEROL, SQUALAMINE IN COMBINATION THERAPY IN THE RAT 13762-MAMMARY-CARCINOMA AND THE MURINE LEWIS LUNG-CARCINOMA

      Anticancer research
    30. CHABNER BA; KASTAN MB; TEICHER BA
      UNTITLED

      Clinical cancer research
    31. TEICHER BA; ARA G; BUXTON D; LEONARD J; SCHAUB RG
      OPTIMAL SCHEDULING OF INTERLEUKIN-12 AND CHEMOTHERAPY IN THE MURINE MB-49 BLADDER-CARCINOMA AND B16 MELANOMA

      Clinical cancer research
    32. EDER JP; WONG JS; CHAN V; TEICHER BA
      IRINOTECAN AND RADIATION IN-VITRO AND IN-VIVO

      International journal of oncology
    33. TEICHER BA; KAKEJI Y; NORTHEY D
      LISOFYLLINE AS AN ADJUVANT TO HIGH-DOSE CYTOTOXIC THERAPY

      International journal of oncology
    34. TEICHER BA; ARA G; NORTHEY D
      INTERACTION OF INTERLEUKIN-11 (RHIL-11) WITH CYTOTOXIC THERAPIES IN THE HUMAN HT-29 COLON-CARCINOMA

      International journal of oncology
    35. TEICHER BA; ARA G; TAKEUCHI H; COLEMAN CN
      TUMOR OXYGENATION AFTER HYPERTHERMIA IN THE RAT 13762-MAMMARY-CARCINOMA AND THE DU-145 HUMAN PROSTATE-CARCINOMA

      International journal of oncology
    36. JONES EL; TEICHER BA; COLEMAN CN; CALDERWOOD SK
      PROSTATE ADENOCARCINOMA APOPTOSIS IN-VIVO FOLLOWING HYPERTHERMIA TREATMENT - IN-VITRO CORRELATES AND CLINICAL IMPLICATIONS

      International journal of radiation oncology, biology, physics
    37. KAKEJI Y; MAEHARA Y; IKEBE M; TEICHER BA
      DYNAMICS OF TUMOR OXYGENATION, CD31 STAINING AND TRANSFORMING GROWTH-FACTOR-BETA LEVELS AFTER TREATMENT WITH RADIATION OR CYCLOPHSOSPHAMIDEIN THE RAT-13762 MAMMARY-CARCINOMA

      International journal of radiation oncology, biology, physics
    38. HOLDEN SA; EMI Y; KAKEJI Y; NORTHEY D; TEICHER BA
      HOST DISTRIBUTION AND RESPONSE TO ANTITUMOR ALKYLATING-AGENTS OF EMT-6 TUMOR-CELLS FROM SUBCUTANEOUS TUMOR IMPLANTS

      Cancer chemotherapy and pharmacology
    39. KAKEJI Y; TEICHER BA
      PRECLINICAL STUDIES OF THE COMBINATION OF ANGIOGENIC INHIBITORS WITH CYTOTOXIC AGENTS

      Investigational new drugs
    40. PALAYOOR ST; BUMP EA; TEICHER BA; COLEMAN CN
      APOPTOSIS AND CLONOGENIC CELL-DEATH IN PC3 HUMAN PROSTATE-CANCER CELLS AFTER TREATMENT WITH GAMMA-RADIATION AND SURAMIN

      Radiation research
    41. NOZUE M; LEE I; YUAN F; TEICHER BA; BRIZEL DM; DEWHIRST MW; MILROSS CG; MILAS L; SONG CW; THOMAS CD; GUICHARD M; EVANS SM; KOCH CJ; LORD EM; JAIN RK; SUIT HD
      INTERLABORATORY VARIATION IN OXYGEN-TENSION MEASUREMENT BY EPPENDORF HISTOGRAPH AND COMPARISON WITH HYPOXIC MARKER

      Journal of surgical oncology
    42. ROSOWSKY A; VAIDYA CM; BADER H; WRIGHT JE; TEICHER BA
      ANALOGS OF -4-DEOXYPTEROYL)-N-DELTA-HEMIPHTHALOYL-L-ORNITHINE (PT523)MODIFIED IN THE SIDE-CHAIN - SYNTHESIS AND BIOLOGICAL EVALUATION

      Journal of medicinal chemistry
    43. TEICHER BA; MAEHARA Y; KAKEJI Y; ARA G; KEYES SR; WONG J; HERBST R
      REVERSAL OF IN-VIVO DRUG-RESISTANCE BY THE TRANSFORMING GROWTH-FACTOR-BETA INHIBITOR DECORIN

      International journal of cancer
    44. IKEBE M; TEICHER BA
      ALTERATIONS IN GENE-EXPRESSION BETWEEN EMT-6 MAMMARY-CARCINOMA MONOLAYERS AND SPHEROIDS IDENTIFIED BY DIFFERENTIAL DISPLAY

      International journal of oncology
    45. ARA G; TEICHER BA
      RELATIONSHIP OF CELLULAR-ENERGY PARAMETERS TO CYTOTOXICITY FOR AG-17,LONIDAMINE AND CYCLOCREATINE IN 4 HUMAN TUMOR-CELL LINES

      International journal of oncology
    46. BERGNES G; YUAN W; KHANDEKAR VS; OKEEFE MM; MARTIN KJ; TEICHER BA; KADDURAHDAOUK R
      CREATINE AND PHOSPHOCREATINE ANALOGS - ANTICANCER ACTIVITY AND ENZYMATIC ANALYSIS

      Oncology research
    47. WONG JS; ARA G; KEYES SR; HERBST R; COLEMAN CN; TEICHER BA
      LISOFYLLINE AS A MODIFIER OF RADIATION-THERAPY

      Oncology research
    48. TEICHER BA; EMI Y; KAKEJI Y; NORTHEY D
      TNP-470 MINOCYCLINE/CYTOTOXIC THERAPY - A SYSTEMS-APPROACH TO CANCER-THERAPY/

      European journal of cancer
    49. ARA G; TEICHER BA
      CYCLOOXYGENASE AND LIPOXYGENASE INHIBITORS IN CANCER-THERAPY

      Prostaglandins, leukotrienes and essential fatty acids
    50. AYASH LJ; ELIAS A; SCHWARTZ G; WHEELER C; IBRAHIM J; TEICHER BA; REICH E; WARREN D; LYNCH C; RICHARDSON P; SCHNIPPER L; FREI E; ANTMAN K
      DOUBLE DOSE-INTENSIVE CHEMOTHERAPY WITH AUTOLOGOUS STEM-CELL SUPPORT FOR METASTATIC BREAST-CANCER - NO IMPROVEMENT IN PROGRESSION-FREE SURVIVAL BY THE SEQUENCE OF HIGH-DOSE MELPHALAN FOLLOWED BY CYCLOPHOSPHAMIDE, THIOTEPA, AND CARBOPLATIN

      Journal of clinical oncology
    51. TEICHER BA; HOLDEN SA; GOFF DA; WRIGHT JE; TRETYAKOV O; AYASH LJ
      ANTITUMOR EFFICACY AND PHARMACOKINETIC ANALYSIS OF 4-HYDROPEROXYCYCLOPHOSPHAMIDE IN COMPARISON WITH CYCLOPHOSPHAMIDE + -HEPATIC ENZYME EFFECTORS/

      Cancer chemotherapy and pharmacology
    52. TEICHER BA; HOLDEN SA; ARA G; KORBUT T; MENON K
      COMPARISON OF SEVERAL ANTIANGIOGENIC REGIMENS ALONE AND WITH CYTOTOXIC THERAPIES IN THE LEWIS LUNG-CARCINOMA

      Cancer chemotherapy and pharmacology
    53. ZHOU GH; TEICHER BA; FREI E
      POSTLABELING DETECTION OF DNA-ADDUCTS OF ANTITUMOR ALKYLATING-AGENTS

      Cancer chemotherapy and pharmacology
    54. TEICHER BA; HOLDEN SA; ARA G; CHEN G
      TRANSFORMING GROWTH-FACTOR-BETA IN IN-VIVO RESISTANCE

      Cancer chemotherapy and pharmacology
    55. TEICHER BA; ARA G; EMI Y; KAKEJI Y; IKEBE M; MAEHARA Y; BUXTON D
      RSR13 - EFFECTS ON TUMOR OXYGENATION AND RESPONSE TO THERAPY

      Drug development research
    56. CHEN G; TEICHER BA; FREI E
      DIFFERENTIAL INTERACTIONS OF PGP INHIBITOR THALIBLASTINE WITH ADRIAMYCIN, ETOPOSIDE, TAXOL AND ANTHRAPYRAZOLE CI941 IN SENSITIVE AND MULTIDRUG-RESISTANT HUMAN MCF-7 BREAST-CANCER CELLS

      Anticancer research
    57. TEICHER BA
      A SYSTEMS-APPROACH TO CANCER-THERAPY (ANTIANGIOGENICS PLUS STANDARD CYTOTOXICS-]MECHANISM(S) OF INTERACTION)

      Cancer metastasis reviews
    58. HALPERN HJ; YU C; PERIC M; BARTH ED; KARCZMAR GS; RIVER JN; GRDINA DJ; TEICHER BA
      MEASUREMENT OF DIFFERENCES IN PO(2) IN RESPONSE TO PERFLUOROCARBON CARBOGEN IN FSA AND NFSA MURINE FIBROSARCOMAS WITH LOW-FREQUENCY ELECTRON-PARAMAGNETIC-RESONANCE OXIMETRY

      Radiation research
    59. TEICHER BA; CHEN YN; ARA G; EMI Y; KAKEJI Y; MAEHARA Y; KEYES S; NORTHEY D
      INTERACTION OF INTERLEUKIN-11 WITH CYTOTOXIC THERAPIES IN-VITRO AGAINST CEM CELLS AND IN-VIVO AGAINST EMT-6 MURINE MAMMARY-CARCINOMA

      International journal of cancer
    60. TEICHER BA; NORTHEY D; YUAN J; FREI E
      HIGH-DOSE THERAPY STEM-CELL SUPPORT - COMPARISON OF MICE AND HUMANS

      International journal of cancer
    61. TEICHER BA; ARA G; MENON K; SCHAUB RG
      IN-VIVO STUDIES WITH INTERLEUKIN-12 ALONE AND IN COMBINATION WITH MONOCYTE COLONY-STIMULATING FACTOR AND OR FRACTIONATED RADIATION TREATMENT/

      International journal of cancer
    62. ANDERSON IC; SHIPP MA; DOCHERTY AJP; TEICHER BA
      COMBINATION THERAPY INCLUDING A GELATINASE INHIBITOR AND CYTOTOXIC AGENT REDUCES LOCAL INVASION AND METASTASIS OF MURINE LEWIS LUNG-CARCINOMA

      Cancer research
    63. TEICHER BA; KAKEJI Y; RICE G; SINGER J
      LISOFYLLINE (LSF) ACCELERATES HEMATOPOIETIC RECOVERY AND ENHANCES TUMOR RESPONSE AFTER HIGH-DOSE CHEMOTHERAPY

      Blood
    64. LIU CN; LAMBERT JM; TEICHER BA; BLATTLER WA; OCONNOR R
      CURE OF MULTIDRUG-RESISTANT HUMAN B-CELL LYMPHOMA XENOGRAFTS BY COMBINATIONS OF ANTI-B4-BLOCKED RICIN AND CHEMOTHERAPEUTIC DRUGS

      Blood
    65. BUBLEY GJ; XU J; KUPIEC N; SANDERS D; FOSS F; OBRIEN M; EMI Y; TEICHER BA; PATIERNO SR
      EFFECT OF DNA CONFORMATION ON CISPLATIN ADDUCT FORMATION

      Biochemical pharmacology
    66. TEICHER BA
      AN OVERVIEW ON OXYGEN CARRIERS IN CANCER-THERAPY

      Artificial cells, blood substitutes, and immobilization biotechnology
    67. DUPUIS NP; KUSUMOTO T; ROBINSON MF; LIU F; MENON K; TEICHER BA
      RESTORATION OF TUMOR OXYGENATION AFTER CYTOTOXIC THERAPY BY A PERFLUBRON EMULSION CARBOGEN BREATHING

      Artificial cells, blood substitutes, and immobilization biotechnology
    68. ROBINSON MF; DUPUIS NP; KUSUMOTO T; LIU F; MENON K; TEICHER BA
      INCREASED TUMOR OXYGENATION AND RADIATION SENSITIVITY IN 2 RAT-TUMORSBY A HEMOGLOBIN-BASED, OXYGEN-CARRYING PREPARATION

      Artificial cells, blood substitutes, and immobilization biotechnology
    69. TEICHER BA
      ANGIOGENESIS AND CANCER METASTASES - THERAPEUTIC APPROACHES

      Critical reviews in oncology/hematology
    70. HOLDEN SA; TEICHER BA
      COMBINATIONS OF TNP-470 OR SR-4233 WITH ANTITUMOR ALKYLATING-AGENTS IN EMT-6 SPHEROIDS AND MONOLAYERS

      International journal of oncology
    71. TEICHER BA; DUPUIS NP; ROBINSON MF; EMI Y; GOFF DA
      ANTIANGIOGENIC TREATMENT (TNP-470 MINOCYCLINE) INCREASES TISSUE-LEVELS OF ANTICANCER DRUGS IN MICE BEARING LEWIS-LUNG-CARCINOMA/

      Oncology research
    72. MARTIN KJ; VASSALLO CD; TEICHER BA; KADDURAHDAOUK R
      MICROTUBULE STABILIZATION AND POTENTIATION ACTIVITY BY THE CREATINE ANALOG CYCLOCREATINE (VOL 6, PG 419, 1995)

      Anti-cancer drugs
    73. MARTIN KJ; VASSALLO CD; TEICHER BA; KADDURAHDAOUK R
      MICROTUBULE STABILIZATION AND POTENTIATION OF TAXOL ACTIVITY BY THE CREATINE ANALOG CYCLOCREATINE

      Anti-cancer drugs
    74. TEICHER BA
      PHYSIOLOGICAL-MECHANISMS OF THERAPEUTIC RESISTANCE - BLOOD-FLOW AND HYPOXIA

      Hematology/oncology clinics of North America
    75. HALPERN HJ; CHANDRAMOULI GVR; YU C; PERIC M; BARTH ED; TEICHER BA; GRDINA D
      PHARMACOLOGICAL COMPARTMENT VISCOSITY AND POLARITY MEASURED WITH VERYLOW-FREQUENCY EPR IN TUMORS OF LIVING ANIMALS

      Magnetic resonance in chemistry
    76. BROOKS SE; KORBUT TT; DUPUIS NP; HOLDEN SA; TEICHER BA
      CYTOTOXICITY OF ANTITUMOR PLATINUM COMPLEXES WITH L-BUTHIONINE-(R,S)-SULFOXIMINE AND OR ETANIDAZOLE IN HUMAN CARCINOMA CELL-LINES SENSITIVEAND RESISTANT TO CISPLATIN/

      Cancer chemotherapy and pharmacology
    77. HOLDEN SA; TEICHER BA; ROBINSON MF; NORTHEY D; ROSOWSKY A
      ANTIFOLATES CAN POTENTIATE TOPOISOMERASE-II INHIBITORS IN-VITRO AND IN-VIVO

      Cancer chemotherapy and pharmacology
    78. HOLDEN SA; TEICHER BA; AYASH LJ; FREI E
      A PRECLINICAL MODEL FOR SEQUENTIAL HIGH-DOSE CHEMOTHERAPY

      Cancer chemotherapy and pharmacology
    79. TEICHER BA; MENON K; NORTHEY D; LIU J; KUFE DW; KADDURAHDAOUK R
      CYCLOCREATINE IN CANCER-CHEMOTHERAPY

      Cancer chemotherapy and pharmacology
    80. CHATTERJEE D; LIU CJT; NORTHEY D; TEICHER BA
      MOLECULAR CHARACTERIZATION OF THE IN-VIVO ALKYLATING AGENT RESISTANT MURINE EMT-6 MAMMARY-CARCINOMA TUMORS

      Cancer chemotherapy and pharmacology
    81. TEICHER BA; DUPUIS NP; LIU F; ROBINSON MF; MENON K
      ADMINISTRATION OF A HEMOGLOBIN SOLUTION DECREASES HYPOXIA AND INCREASES RADIATION RESPONSE IN A RAT MAMMARY-CARCINOMA

      Drug development research
    82. TEICHER BA; HOLDEN SA; ARA G; MENON K
      WHOLE-BODY HYPERTHERMIA AND LONIDAMINE AS ADJUVANT THERAPY TO TREATMENT WITH CISPLATIN WITH OR WITHOUT LOCAL RADIATION IN MOUSE BEARING THELEWIS LUNG-CARCINOMA

      International journal of hyperthermia
    83. BORNSTEIN BA; HERMAN TS; HANSEN JL; BUSWELL L; ZOURANJIAN PS; FRASER SM; TEICHER BA; SVENSSON GK; COLEMAN CN
      PILOT-STUDY OF LOCAL HYPERTHERMIA, RADIATION-THERAPY, ETANIDAZOLE, AND CISPLATIN FOR ADVANCED SUPERFICIAL TUMORS

      International journal of hyperthermia
    84. KUSUMOTO T; HOLDEN SA; ARA G; TEICHER BA
      HYPERTHERMIA AND PLATINUM COMPLEXES - TIME BETWEEN TREATMENTS AND SYNERGY IN-VITRO AND IN-VIVO

      International journal of hyperthermia
    85. TEICHER BA; HOLDEN SA; DUPUIS NP; KAKEJI Y; IKEBE M; EMI Y; GOFF D
      POTENTIATION OF CYTOTOXIC THERAPIES BY TNP-470 AND MINOCYCLINE IN MICE BEARING EMT-6 MAMMARY-CARCINOMA

      Breast cancer research and treatment
    86. TEICHER BA; HOLDEN SA; ARA G; DUPUIS NP; LIU F; YUAN J; IKEBE M; KAKEJI Y
      INFLUENCE OF AN ANTI-ANGIOGENIC TREATMENT ON 9L GLIOSARCOMA - OXYGENATION AND RESPONSE TO CYTOTOXIC THERAPY

      International journal of cancer
    87. EDER JP; CHAN VTW; NG SW; RIZVI NA; ZACHAROULIS S; TEICHER BA; SCHNIPPER LE
      DNA TOPOISOMERASE-II-ALPHA EXPRESSION IS ASSOCIATED WITH ALKYLATING AGENT RESISTANCE

      Cancer research
    88. OCONNOR R; LIU CN; FERRIS CA; GUILD BC; TEICHER BA; CORVI C; LIU YM; ARCECI RJ; GOLDMACHER VS; LAMBERT JM; BLATTLER WA
      ANTI-B4-BLOCKED RICIN SYNERGIZES WITH DOXORUBICIN AND ETOPOSIDE ON MULTIDRUG-RESISTANT AND DRUG-SENSITIVE TUMORS

      Blood
    89. TEICHER BA; HOLDEN SA; CHEN YN; MENON K
      INTERACTION OF RECOMBINANT HUMAN INTERLEUKIN-11 WITH CYTOTOXIC CANCERTHERAPIES IN-VITRO AND IN-VIVO

      Blood
    90. PASQUALUCCI L; WASIK M; TEICHER BA; FLENGHI L; BOLOGNESI A; STIRPE F; POLITO L; FALINI B; KADIN ME
      ANTITUMOR-ACTIVITY OF ANTI-CD30 IMMUNOTOXIN (BER-H2 SAPORIN) IN-VITROAND IN SEVERE COMBINED IMMUNODEFICIENCY DISEASE MICE XENOGRAFTED WITHHUMAN CD30(-CELL LYMPHOMA() ANAPLASTIC LARGE)

      Blood
    91. TEICHER BA
      COMBINATION OF PERFLUOROCHEMICAL EMULSIONS AND CARBOGEN BREATHING WITH CANCER-CHEMOTHERAPY

      Artificial cells, blood substitutes, and immobilization biotechnology
    92. TEICHER BA; SCHWARTZ GN; DUPUIS NP; KUSOMOTO T; LIU M; LIU F; NORTHEY D
      OXYGENATION OF HUMAN TUMOR XENOGRAFTS IN NUDE-MICE BY A PERFLUOROCHEMICAL, EMULSION AND CARBOGEN BREATHING

      Artificial cells, blood substitutes, and immobilization biotechnology
    93. TEICHER BA; HOLDEN SA; DUPUIS NP; KUSOMOTO T; LIU M; LIU F; MENON K
      OXYGENATION OF THE RAT-9L GLIOSARCOMA AND THE RAT-13672 MAMMARY-CARCINOMA WITH VARIOUS DOSES OF A HEMOGLOBIN SOLUTION

      Artificial cells, blood substitutes, and immobilization biotechnology
    94. TEICHER BA; HOLDEN SA; HERMAN TS; NORTHEY D
      MODULATION OF [CIS-DIAMINEDICHLOROPLATINUM(II) HYPERTHERMIA] THERAPY BY INHIBITORS OF ARACHIDONIC-ACID METABOLISM

      International journal of oncology
    95. TEICHER BA
      LONIDAMINE - IN-VITRO IN-VIVO CORRELATIONS

      European journal of cancer
    96. TEICHER BA
      LONIDAMINE - IN-VITRO IN-VIVO CORRELATIONS

      European journal of cancer
    97. TEICHER BA; HOLDEN SA; CHEN YN; ARA G; KORBUT TT; NORTHEY D
      CAI - EFFECTS ON CYTOTOXIC THERAPIES IN-VITRO AND IN-VIVO

      Cancer chemotherapy and pharmacology
    98. TEICHER BA; SCHWARTZ JL; HOLDEN SA; ARA G; NORTHEY D
      IN-VIVO MODULATION OF SEVERAL ANTICANCER AGENTS BY BETA-CAROTENE

      Cancer chemotherapy and pharmacology
    99. TEICHER BA; KORBUT TT; MENON K; HOLDEN SA; ARA G
      CYCLOOXYGENASE AND LIPOXYGENASE INHIBITORS AS MODULATORS OF CANCER THERAPIES

      Cancer chemotherapy and pharmacology
    100. HOLDEN SA; TEICHER BA; FREI E
      LONG-TERM PERSISTENCE AND CYTOKINETICS OF HUMAN TUMOR-CELLS IN-VITRO FOLLOWING HIGH-DOSE ALKYLATING AGENT EXPOSURE IT

      Cancer letters


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 13/08/20 alle ore 02:52:46